3.90
Lifemd Inc stock is traded at $3.90, with a volume of 594.46K.
It is up +0.64% in the last 24 hours and up +41.49% over the past month.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
See More
Previous Close:
$3.88
Open:
$3.9
24h Volume:
594.46K
Relative Volume:
0.50
Market Cap:
$187.10M
Revenue:
$234.96M
Net Income/Loss:
$-4.30M
P/E Ratio:
-19.62
EPS:
-0.1988
Net Cash Flow:
$-1.24M
1W Performance:
-4.99%
1M Performance:
+41.49%
6M Performance:
-37.22%
1Y Performance:
-34.92%
Lifemd Inc Stock (LFMD) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
(866) 351-5907
Address
236 FIFTH AVENUE, NEW YORK
Compare LFMD vs VEEV, BTSG, TEM, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
LFMD
Lifemd Inc
|
3.90 | 186.14M | 234.96M | -4.30M | -1.24M | -0.1988 |
|
VEEV
Veeva Systems Inc
|
178.11 | 29.44B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
44.82 | 8.32B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
TEM
Tempus Ai Inc
|
46.76 | 8.73B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
HQY
Healthequity Inc
|
82.47 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
WAY
Waystar Holding Corp
|
24.14 | 4.61B | 1.10B | 112.09M | 283.19M | 0.6096 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-16-26 | Upgrade | Mizuho | Neutral → Outperform |
| Jun-18-25 | Reiterated | BTIG Research | Buy |
| Dec-10-24 | Initiated | Lake Street | Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-23-24 | Resumed | B. Riley Securities | Buy |
| Jun-05-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-30-23 | Initiated | Craig Hallum | Buy |
| Jul-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-03-23 | Initiated | H.C. Wainwright | Buy |
| Mar-10-22 | Initiated | Colliers Securities | Buy |
| Oct-04-21 | Resumed | B. Riley Securities | Buy |
View All
Lifemd Inc Stock (LFMD) Latest News
How Lifemd Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) Affects Rotational Strategy Timing - Stock Traders Daily
LifeMD, Inc. 8.875% CUM PFD A declares $0.5547 dividend - MSN
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - The Manila Times
Hims & Hers Expands Integrated Digital Healthcare Ecosystem - TradingView
[144] LifeMD, Inc. SEC Filing - Stock Titan
LifeMD appoints Atul Kavthekar as CFO - MSN
If You Invested $1,000 in Lifemd, Inc. (LFMDP) - Stock Titan
If You Invested $1,000 in Lifemd Inc (LFMD) - Stock Titan
LifeMD appoints new CFO; shares up - MSN
How The LifeMD (LFMD) Story Is Shifting On GLP‑1 Growth And Higher 2026 Targets - Yahoo Finance
LifeMD Appoints Atul Kavthekar as CFO and Expands Leadership Team to Drive AI-First Healthcare Growth 1 - Minichart
LifeMD Announces CFO Transition and Expanded Leadership Team - TipRanks
LifeMD (NASDAQ: LFMD) installs new CFO and expands leadership team - Stock Titan
LifeMD (LFMD) to Participate in B. Riley's Virtual Meeting on Ma - GuruFocus
Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD), Immatics (IMTX) and BrightSpring Health Services, Inc. (BTSG) - The Globe and Mail
LifeMD, Inc. (NASDAQ:LFMD) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
LifeMD names Atul Kavthekar as CFO, announces leadership changes By Investing.com - Investing.com India
LifeMD, Inc. Announces Chief Financial Officer Changes - marketscreener.com
Lifemd, Inc. Announces Executive Appointments - marketscreener.com
LifeMD shares are trading higher after the co... - Benzinga
LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team - markets.businessinsider.com
LifeMD Inc announced appointment of Atul Kavthekar as chief financial officer - marketscreener.com
LifeMD names Atul Kavthekar as CFO, announces leadership changes - Investing.com
LifeMD (NASDAQ:LFMD) Raised to Outperform at Mizuho - MarketBeat
LifeMD Inc Announced Appointment Of Atul Kavthekar As Chief Financial Officer - TradingView
This Upstart Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Benzinga
Mizuho Upgrades LifeMD (LFMD) with Raised Price Target to $8.00 - GuruFocus
Mizuho upgrades LifeMD stock rating on weight-loss outlook By Investing.com - Investing.com Australia
Mizuho upgrades LifeMD stock rating on weight-loss outlook - Investing.com Nigeria
LifeMD outlines $250M+ annualized revenue run rate target by Q4 2026 amid record GLP-1 demand and expanded partnerships - MSN
LifeMD (LFMD) Is Up 32.7% After Returning To Profitability And Expanding GLP‑1 Telehealth Offerings - simplywall.st
LifeMD (NASDAQ:LFMD) Upgraded to Hold at Wall Street Zen - MarketBeat
H.C. Wainwright raises LifeMD stock price target to $10 on results - Investing.com Nigeria
HC Wainwright Issues Positive Forecast for LifeMD Earnings - MarketBeat
A Look At LifeMD (LFMD) Valuation After Profitability Return And 2026 Growth Guidance - Yahoo Finance
LifeMD (LFMD) Valuation Check After Earnings Beat Guidance Update And Wegovy Partnership - simplywall.st
LifeMD, Inc. (LFMD) reports Q4 loss, tops revenue estimates - MSN
LifeMD (LFMD) Analyst Rating: Freedom Capital Markets Raises Pri - GuruFocus
Hims & Hers Plunges 29.4% in Three Months: How to Play the Stock? - TradingView
Freedom Capital Markets raises LifeMD stock price target on forecast boost By Investing.com - Investing.com South Africa
Freedom Capital Markets raises LifeMD stock price target on forecast boost - Investing.com Nigeria
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Centene (CNC) and LifeMD (LFMD) - The Globe and Mail
LifeMD surges 11.5% on Q4 earnings beat, FY guidance By Investing.com - Investing.com Nigeria
LifeMD: Wegovy Pill, Net Cash, And Low Multiple Sets Up Longs For Possible Alpha - Seeking Alpha
LifeMD, Inc. 2025 Annual Report: Virtual Healthcare, Telehealth Growth, and Integrated Pharmacy Platform 101 - Minichart
HC Wainwright Increases LifeMD (NASDAQ:LFMD) Price Target to $10.00 - MarketBeat
LifeMD (LFMD): HC Wainwright Raises Price Target While Maintaini - GuruFocus
Lifemd Inc Stock (LFMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lifemd Inc Stock (LFMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FRIEDEMAN JESSICA | Chief Marketing Officer |
Dec 09 '25 |
Sale |
3.61 |
15,000 |
54,158 |
205,000 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):